UKPOL.CO.UK

Category: Speeches

  • Stephen Timms – 2016 Parliamentary Question to the Department for Education

    Stephen Timms – 2016 Parliamentary Question to the Department for Education

    The below Parliamentary question was asked by Stephen Timms on 2016-05-05.

    To ask the Secretary of State for Education, for what reason the school specific factors and historic grant factors elements of the payment by the Education Funding Authority to the King David School, Manchester, were reduced by over £1 million in 2013-14.

    Mr Sam Gyimah

    In 2012-13 King David School received £1.1 million in School Specific factors and Historic Grant funding. For 2013-14 local funding formulae were simplified and the number of allowable formula factors was reduced. This meant that any funding previously allocated through other factors such as Historic Grants had to be moved into one of the allowable factors. Manchester LA chose to distribute this funding at pupil level in 2013-14 using the Age Weighted Pupil Unit (AWPU) factor, the sum of money allocated to the school for each pupil according to age. As such, King David School received an increase of £630,000 in AWPU for 2013-14. Schools were also protected against losses from the introduction of the new formula using a minimum funding guarantee (MFG). In 2013-14 King David School received an increase of £430,000 under the MFG. Overall pre-16 School Budget share funding (including MFG) for the school was £3,239,833 for 596 pupils in 2012-13 and £3,236,489 for 586 pupils in 2013-14.

  • Jim Shannon – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Jim Shannon – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Jim Shannon on 2016-06-27.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what recent reports he has received on the relocation of Bahraini citizenship from Sheikh Isa Qassim.

    Mr Tobias Ellwood

    We are concerned by reports that the nationality of Bahraini Shia cleric Sheikh Isa Qassim is being revoked, and we have raised these concerns at senior levels in the Bahraini government and publicly. We strongly encourage Bahrain to live up to its international human rights obligations.

  • Thangam Debbonaire – 2016 Parliamentary Question to the Department for International Trade

    Thangam Debbonaire – 2016 Parliamentary Question to the Department for International Trade

    The below Parliamentary question was asked by Thangam Debbonaire on 2016-09-14.

    To ask the Secretary of State for International Trade, what steps he is taking to determine how many trade negotiators his Department will require in the next six months.

    Greg Hands

    The Department for International Trade already has a strong and capable trade policy team which has more than doubled in size since 23 June. Over the coming months we will be developing that team to build the world class negotiating strengths needed to deliver the best outcomes for the UK. They will have the depth and breadth of expertise to handle the full range of sectoral and cross-cutting issues that arise in trade agreements, supported by analysts and lawyers.

  • Luciana Berger – 2015 Parliamentary Question to the Department of Health

    Luciana Berger – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2015-11-18.

    To ask the Secretary of State for Health, what steps he is taking to address the higher incidence of mental illness among young LGBT people.

    Alistair Burt

    In line with guidance published by NHS England in August, clinical commissioning groups (CCGs) have produced Local Transformation Plans (LTPs) for children and young people’s mental health with their local partners as proposed in Future in Mind. These include plans for how CCGs will ensure that the needs of all vulnerable groups are met locally, including the needs of those with protected characteristics. This includes Lesbian, Gay, Bisexual, Transgender (LGBT) children and young people. In addition, the guidance issued by NHS England in August made specific reference to the need to promote equality and address health inequalities in the LTPs.

    While Future in Mind did not specifically mention LGBT teens as a vulnerable group, the Vulnerable Groups and Inequalities Task and Finish group Report, one of four task and finish group reports published alongside Future in Mind, did specifically mention and consider LGBT children and young people.

    CCGs have a legal duty to have regard to tackling health inequalities including inequalities in mental health when planning how they will commission services.

  • Lord Hylton – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    Lord Hylton – 2015 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Lord Hylton on 2015-12-09.

    To ask Her Majesty’s Government whether they have discussed, or have any plans to discuss, with the government of Israel, the impact of exit permit restrictions on inhabitants of Gaza and the West Bank who seek medical treatment elsewhere.

    Baroness Anelay of St Johns

    While we have not discussed this issue with the Israeli authorities, we remain deeply concerned about restrictions on freedom of movement in the Occupied Palestinian Territories. Our Ambassador in Tel Aviv raised the issue of freedom of movement with Israeli National Security Advisor Cohen on 2 November. Our Consul-General to Jerusalem also raised this issue with the Mayor of Jerusalem on 28 October.

  • Ian C. Lucas – 2016 Parliamentary Question to the Department for Transport

    Ian C. Lucas – 2016 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Ian C. Lucas on 2016-01-20.

    To ask the Secretary of State for Transport, pursuant to the Answer of 11 January 2016 to Question 20950, which routes would offer greater benefits from the additional paths referred to in that answer than the proposal from Arriva Trains Wales.

    Claire Perry

    The successful bidder for the new Northern franchise has proposed new direct links between Manchester Airport and Bradford (via Rochdale, Halifax and the Calder Valley), and between Manchester Airport and Liverpool (via Warrington Central). It will be for the Office of Rail and Road to determine the allocation of scarce capacity to/from Manchester Airport between the competing potential uses.

  • Jim Shannon – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    Jim Shannon – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Jim Shannon on 2016-02-08.

    To ask the Secretary of State for Business, Innovation and Skills, how many post offices are earmarked for closure in the next three years.

    George Freeman

    Government’s funding arrangements for Post Office Limited require them to maintain a network that meets nationwide access criteria.

    Within that framework, the provision of post offices is the operational responsibility of Post Office Limited. I have therefore asked Paula Vennells, the Chief Executive of Post Office Limited, to write to you on this matter. A copy of her reply will be placed in the libraries of the House.

  • Tom Watson – 2016 Parliamentary Question to the Cabinet Office

    Tom Watson – 2016 Parliamentary Question to the Cabinet Office

    The below Parliamentary question was asked by Tom Watson on 2016-03-03.

    To ask the Minister for the Cabinet Office, whether the Government plans to bring forward legislative proposals to extend the scope of the Freedom of Information Act 2000 to include private sector companies that deliver public services.

    Matthew Hancock

    I refer the hon Member to my Written Ministerial Statement of 1 March 2016 [Hansard reference HCWS566]

  • Lord Myners – 2016 Parliamentary Question to the HM Treasury

    Lord Myners – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Lord Myners on 2016-04-12.

    To ask Her Majesty’s Government what assessment they have made of whether the proposed takeover of the London Stock Exchange by Deutsche Börse gives rise to issues of national importance.

    Lord O’Neill of Gatley

    I refer the noble Lord to the investor relations section of the London Stock Exchange Group website, which contains information about the proposed merger, including some information on the combined group’s proposed structure. I also refer the noble Lord to my previous written answer HL7153.

    Once formally notified of the proposed merger, the Bank of England and the Financial Conduct Authority (as supervisors of the London Stock Exchange Group’s UK-authorised subsidiaries) must assess the proposal from a regulatory standpoint.

    In addition the proposed merger must be approved by competition authorities and is subject to a range of other assessments including those of overseas regulators and shareholders.

    European Regulation No 648/2012 (EMIR) sets out detailed standards on the quality of collateral that a central counterparty (CCP) can accept, and includes a general requirement that the CCP can demonstrate to its supervisor that the form of collateral in question does not present unmanageable risk to the CCP. Furthermore, CCPs are permitted under EMIR to invest their collateral “only in cash or in highly liquid financial instruments with minimal market and credit risk.”

    Any proposals for inter-CCP links would need to be assessed against relevant parts of EMIR by the Bank of England, as supervisor of LCH. EMIR requires that models used to set CCP margin requirements (and any changes to them) are validated by the CCP’s supervisor. EMIR also requires that a CCP wishing to extend its business to additional products or services must obtain the authorisation of its supervisor.

  • Cat Smith – 2016 Parliamentary Question to the Department of Health

    Cat Smith – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Cat Smith on 2016-05-05.

    To ask the Secretary of State for Health, if he will conduct an investigation into historical cases of birth defects caused by sodium valproate and the support now required by the families affected.

    George Freeman

    Valproate is an effective treatment for epilepsy and bipolar disorder but should only be used in girls and women of childbearing potential if other treatments are ineffective or not tolerated. For some women there may be no other treatment option. Since it was authorised, valproate was known to have risks in pregnancy. Because of ongoing concerns about women’s awareness of the risks, the Medicines and Healthcare products Regulatory Agency (MHRA) has worked with professional bodies, voluntary organisations and patient groups to develop a set of materials to aid communication between health professionals and women and girls.

    The valproate toolkit comprises booklets for healthcare professionals, a reminder card and a guide for women, a checklist for prescribers and clear package labelling carrying a prominent warning about use in pregnancy. It was widely disseminated on 8 February 2016 through a Central Alerting System (a web based cascade system for issuing alerts to the National Health Service) and the MHRA’s Drug Safety Update bulletin. Electronic copies of the toolkit are hosted on several websites including the Electronic Medicines Compendium. Letters and hard copies of the toolkit were sent by the marketing authorisation holder directly to general practitioners (GPs), pharmacists and relevant specialists. This included 400,000 patient cards, 81,000 patient guides and 22,000 healthcare professional booklets.

    In order to monitor the effectiveness of the valproate toolkit, the MHRA has sought feedback from all stakeholders and will continue to work with the Royal Colleges, professional bodies including the Royal Pharmaceutical Society, patient groups and relevant charities to increase awareness of the toolkit among GPs, pharmacists and patients.This work will include exploring how clinical commissioning groups can help ensure the toolkit materials are being used.

    So far, the MHRA has worked with voluntary organisations and patient groups to produce online patient surveys to measure awareness of the risks among patients. Furthermore, MHRA is conducting a study using the Clinical Practice Research Datalink to track changes in prescribing of valproate to women and girls following the communications to healthcare professionals and patients on the risks of valproate in pregnancy. The marketing authorisation holder is conducting Europe-wide studies to measure the changes in patterns of prescribing and awareness of the healthcare professionals of the risks. The available data will be brought together in a regularly updated dashboard that will be used to track the impact of the communications on patient and professional awareness over time.

    The Government has great sympathy for those families who have been affected by the use of valproate in pregnancy. There is support available for families with children born with a disability. For many people this will involve an early intervention programme from health visitors and midwives, to help a child develop, as well as provide support to the family. This might include: speech and language therapy – to help with any problems communicating or feeding; physiotherapy – to help with any muscle weakness or movement difficulties, and individual home teaching programmes.

    Where a child has a special educational need the local authority must make support available to ensure the child had access to the same educational opportunities as a child without such a need. The Children and Families Act 2014 introduced a new statutory framework for local authorities and to work together to secure services for children and young people – up to the age of 25 – who have special educational needs or disability, across education, health and social care.

    The MHRA’s current priority is to work to ensure that women taking valproate are fully aware of the risks in pregnancy. Once this is achieved we will look into the history of the episode and see what lessons have been or could be usefully learnt by examining events.